Conventional delivery methods lead to systemic distribution rather than targeting specific tissues or cells under oxidative stress, reducing effectiveness and increasing the required dosage as reported by Sezgin-Bayindir et al
Although the primary impact of Semaglutide is on glucose metabolism and appetite regulation through GLP-1 receptor pathways, there exists an indirect possibility for these mechanisms to affect blood flow
Collectively, these findings support a role for GLP-1RAs in strengthening antitumor T-cell immunity mainly through TME remodeling, with particularly evident effects under obesity-associated metabolic conditions (111)
Exercise alone led to similar fitness benefits as the combined treatment, while liraglutide alone did not improve physical fitness
KnopFKArodaVRdo ValeRDHolst-HansenTLaursenPNRosenstockJet alOral semaglutide 50mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Diabetes, obesity and metabolism 2020;22:2451-9